Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-07-09 | 2020-09-03 | 119895 |
TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119898 |
TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120229 |
TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2020-10-22 | 120232 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120238 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120241 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120244 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120247 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120250 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2022-03-26 | 120253 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120256 |
TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120259 |
TEVA-VARENICLINE | 1MG | TABLET | Resolved | 2020-07-14 | 2020-08-04 | 120262 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-07-14 | 2020-09-04 | 120271 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-07-14 | 2020-09-03 | 120282 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120303 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120306 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120309 |
TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120312 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |